Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients

NCT02008942 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: PL2200 Aspirin Capsules
DRUG: Enteric-coated aspirin caplets

Sponsor

PLx Pharma